{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:53Z","timestamp":1787028653949,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Society of Cataract and Refractive Surgeons (ESCRS) Pioneer Research Award"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Anterior blepharitis (AB) is a chronic eyelid inflammation with no definitive cure. Objectives: To assess the safety and efficacy of a 1% povidone-iodine (PVI) ophthalmic solution lid scrub compared to formulated eyelid wipes in treating AB. Design: A prospective, randomized, controlled, observer-masked, paired-eye trial. Methods: Sixty-three AB patients were randomly assigned to a 30-day treatment in which one eye underwent a daily lid scrub with 1% PVI solution (1% PVI group), while the fellow eye was treated with formulated eyelid wipes (control group). Clinical outcomes, such as blepharitis signs, tear breakup time, and corneal staining, were evaluated at study enrollment and exit visits. Symptom assessments utilized the visual analog scale (VAS) per eye and the ocular surface disease index (OSDI) questionnaire. Results: Fifty-two patients (mean age 62.3 years, 53.8% females) completed the treatment, while seven patients were lost to follow-up, three were non-compliant, and one sustained an eye trauma. After 30 days, both the 1% PVI and control groups exhibited significant improvements in symptoms, blepharitis signs, and corneal staining (p &lt; 0.05). The 1% PVI scrubs were equally effective as eyelid wipes in most outcomes (p = 0.480) and superior in alleviating eyelid erythema (p = 0.007). Only the 1% PVI group showed a positive correlation between OSDI and VAS score improvements (r (52) = 0.353, p = 0.01). No adverse events related to either treatment modality were reported. Conclusions: A 1% PVI solution is an effective, safe, and well-tolerated treatment option for AB and is superior to formulated eyelid wipes in several subjective and objective measures.<\/jats:p>","DOI":"10.3390\/jcm13237227","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:28:01Z","timestamp":1732778881000},"page":"7227","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of 1% Povidone-Iodine in the Treatment of Anterior Blepharitis\u2014Randomized Single-Center Controlled Trial"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2333-9923","authenticated-orcid":false,"given":"Elishai","family":"Assayag","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9103102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Abulafia","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9103102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Teren","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9103102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9167-1587","authenticated-orcid":false,"given":"Evgeny","family":"Gelman","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9103102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Givoni","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9103102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zadok","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9103102, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"P56","DOI":"10.1016\/j.ophtha.2018.10.019","article-title":"Blepharitis Preferred Practice Pattern\u00ae","volume":"126","author":"Amescua","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1542-0124(12)70620-1","article-title":"Blepharitis in the United States 2009: A survey-based perspective on prevalence and treatment","volume":"7","author":"Lemp","year":"2009","journal-title":"Ocul. Surf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","article-title":"Classification of Chronic Blepharitis","volume":"89","author":"McCulley","year":"1982","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jtos.2014.05.005","article-title":"Treatment of blepharitis: Recent clinical trials","volume":"12","author":"Pflugfelder","year":"2014","journal-title":"Ocul. Surf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2017.10.005","article-title":"Randomized double-masked trial of eyelid cleansing treatments for blepharitis","volume":"16","author":"Sung","year":"2018","journal-title":"Ocul. Surf."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ICO.0000000000003097","article-title":"Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)","volume":"42","author":"Yeu","year":"2023","journal-title":"Cornea"},{"key":"ref_7","first-page":"1","article-title":"Interventions for chronic blepharitis","volume":"5","author":"Lindsley","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.00682-20","article-title":"Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization","volume":"64","author":"Lepelletier","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","article-title":"The use of povidone-iodine in ophthalmology","volume":"29","author":"Grzybowski","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"xx","DOI":"10.1016\/j.ajo.2017.11.021","article-title":"Endophthalmitis: Then and Now","volume":"187","author":"Relhan","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40123-015-0040-4","article-title":"Rosacea Blepharoconjunctivitis Treated with a Novel Preparation of Dilute Povidone Iodine and Dimethylsulfoxide: A Case Report and Review of the Literature","volume":"4","author":"Pelletier","year":"2015","journal-title":"Ophthalmol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40123-017-0097-3","article-title":"Demodex Blepharitis Treated with a Novel Dilute Povidone-Iodine and DMSO System: A Case Report","volume":"6","author":"Pelletier","year":"2017","journal-title":"Ophthalmol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00417-012-2001-0","article-title":"Successful treatment of blepharitis with bibrocathol (Posiformin\u00ae 2%)","volume":"250","author":"Bezdetko","year":"2012","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_14","unstructured":"Efron, N. (2000). Efron Grading Scales for Contact Lens Complications (Millennium Edition), Butterworth-Heinemann."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ICO.0000000000002802","article-title":"Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis","volume":"41","author":"Choi","year":"2022","journal-title":"Cornea"},{"key":"ref_16","unstructured":"(2024, November 01). American Academy of Ophthalmology NEI\/Industry Grading System\u2014American Academy of Ophthalmology. Available online: https:\/\/www.aao.org\/education\/image\/neiindustry-grading-system."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the ocular surface disease index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/bjophthalmol-2020-317473","article-title":"Assessment of patient burden from dry eye disease using a combination of five visual analogue scales and a radar graph: A pilot study of the PENTASCORE","volume":"106","author":"Labetoulle","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9394(14)72383-9","article-title":"Role of cell-mediated immunity to staphylococci in blepharitis","volume":"111","author":"Ficker","year":"1991","journal-title":"Am. J. Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/OPTO.S142708","article-title":"Demodex blepharitis: Clinical perspectives","volume":"10","author":"Fromstein","year":"2018","journal-title":"Clin. Optom."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhu, M., Cheng, C., Yi, H., Lin, L., and Wu, K. (2018). Quantitative Analysis of the Bacteria in Blepharitis with Demodex Infestation. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01719"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0181-5512(05)81007-1","article-title":"Malassezia fungal blepharitis: A case report","volume":"28","author":"Derbel","year":"2005","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/jcm.21.6.991-992.1985","article-title":"Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus","volume":"21","author":"Haley","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jor.21110","article-title":"Anti-biofilm activity of sub-inhibitory povidone-iodine concentrations against Staphylococcus epidermidis and Staphylococcus aureus","volume":"28","author":"Oduwole","year":"2010","journal-title":"J. Orthop. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/jcm.15.4.635-639.1982","article-title":"Increased bactericidal activity of dilute preparations of povidone-iodine solutions","volume":"15","author":"Berkelman","year":"1982","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-011-9458-y","article-title":"Comparison of Antifungal Activities of Gentian Violet and Povidone-Iodine Against Clinical Isolates of Candida Species and Other Yeasts: A Framework to Establish Topical Disinfectant Activities","volume":"173","author":"Kondo","year":"2012","journal-title":"Mycopathologia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1111\/aos.14243","article-title":"In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM\u00ae)","volume":"98","author":"Pinna","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bjo.2005.072363","article-title":"In vitro and in vivo killing of ocular Demodex by tea tree oil","volume":"89","author":"Gao","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2147\/OPTH.S114674","article-title":"DEBS\u2014A unification theory for dry eye and blepharitis","volume":"10","author":"Rynerson","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2147\/OPTH.S374530","article-title":"Psychosocial Impact of Demodex Blepharitis","volume":"16","author":"Dierker","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s00417-023-06104-2","article-title":"Developing and validating a questionnaire to assess the symptoms of blepharitis accompanied by dry eye disease","volume":"261","author":"Li","year":"2023","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.burns.2007.11.014","article-title":"Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel\u00ae) for wound healing in vitro","volume":"34","author":"Beukelman","year":"2008","journal-title":"Burns"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lee, S.H., Choi, M.R., Chung, J., Choi, S.H., Park, S.K., and Kim, Y.M. (2022). Povidone iodine suppresses LPS-induced inflammation by inhibiting TLR4\/MyD88 formation in airway epithelial cells. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-07803-2"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/ICO.0000000000002148","article-title":"Efficacy of the Fluorescein Tear Breakup Time Test in Dry Eye","volume":"39","author":"Paugh","year":"2020","journal-title":"Cornea"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/j.jcrs.0000000000001436","article-title":"In Vivo Assessment of Antimicrobial Activity and Toxicity of Repeated 1% Povidone\u2013Iodine Applications vs a Single 5% Povidone\u2013Iodine Application","volume":"50","author":"Teren","year":"2024","journal-title":"J. Cataract Refract. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/ICL.0000000000000258","article-title":"Compliance and Subjective Patient Responses to Eyelid Hygiene","volume":"43","author":"Alghamdi","year":"2017","journal-title":"Eye Contact Lens"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.ICL.0000095229.01957.89","article-title":"Conservative treatment of meibomian gland dysfunction","volume":"30","author":"Romero","year":"2004","journal-title":"Eye Contact Lens"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jcjo.2020.05.015","article-title":"Is there enough evidence for the routine recommendation of eyelid wipes? A systematic review of the role of eyelid wipes in the management of blepharitis","volume":"55","author":"Gostimir","year":"2020","journal-title":"Can. J. Ophthalmol."},{"key":"ref_39","first-page":"895","article-title":"Chamomile: A herbal medicine of the past with a bright future (review)","volume":"3","author":"Srivastava","year":"2010","journal-title":"Mol. Med. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.2008.08643.x","article-title":"Glycerol and the skin: Holistic approach to its origin and functions","volume":"159","author":"Fluhr","year":"2008","journal-title":"Br. J. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7227\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:41:23Z","timestamp":1760114483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":40,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13237227"],"URL":"https:\/\/doi.org\/10.3390\/jcm13237227","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}